Author

T. Shao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1 Paleontology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

J. Chen· 2 shared Y. Chen· 2 shared Y. Wang· 2 shared A. Aravind· 1 shared A. Haider· 1 shared B. Duan· 1 shared C. Chen· 1 shared C. Lu· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. Chen

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response

L. Zhang, Y. Jiang, J. He, J. Chen, R. Qi, L. Yuan, T. Shao, C. Chen, Y. Chen, X. Wang, X. Lei, Q. Gao, C. Zhuang, M. Zhou, J. Ma, , N. Xia

This study evaluates an intranasal influenza-based vaccine against SARS-CoV-2 variants, showing it reduces inflammatory response and tissue damage through local immunity.

bioRxiv · Oct 3, 2022 · PreprintImmunology

Circulating tumor DNA profiling approach based on in silico background elimination guides patient classification of multiple cancers

M. Li, S. Xie, T. Hou, T. Shao, J. Kuang, C. Lu, X. Liu, L. Zhu, L. Zhu

The paper introduces MaGIC, a ctDNA profiling method that improves cancer classification and chemosensitivity prediction by reducing background noise from cfDNA.

bioRxiv · Aug 4, 2022 · PreprintCancer Biology

Development of a Triazolobenzodiazepine-Based PET Probe for Subtype-Selective Vasopressin 1A Receptor Imaging

A. Haider, Z. Xiao, X. Xia, J. Chen, R. S. Van, S. Kuang, C. Zhao, J. Rong, T. Shao, P. Ramesh, A. Aravind, Y. Shao, C. Ran, L. Young, S. H. Liang

This paper develops a PET probe for subtype-selective V1A receptor imaging in peripheral organs, showing high affinity and selectivity for V1A over other vasopressin receptors.

bioRxiv · Feb 9, 2021Pharmacology & Toxicology

Blocking of EGFR Signaling is a Latent Strategy for the Improvement of Prognosis of HPV Induced Cancer

J. Qiu, F. Hu, T. Shao, Y. Guo, Z. Dai, H. Nie, O. I. Olasunkanmi, Y. Chen, L. Lin, W. Zhao, Z. Zhong, Y. Wang

This study identifies EGFR downregulation as a mechanism by which HPV infection improves prognosis in cervical and head and neck cancers, suggesting EGFR inhibitors could be potential anti-HPV therapies.

bioRxiv · Oct 6, 2020 · PreprintMicrobiology

An early Cambrian ecdysozoan with a terminal mouth but no anus

Y. Liu, H. Zhang, S. Xiao, T. Shao, B. Duan

This paper reclassifies Saccorhytus coronarius as an early Cambrian ecdysozoan lacking an anus, challenging previous deuterostome interpretations.

bioRxiv · Sep 4, 2020 · PreprintPaleontology